A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma

A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma

Background SM-11355 is a platinum complex developed to treat hepatocellular carcinoma (HCC) via administration into the hepatic artery as a sustained-release suspension in iodized oil. We conducted a multicenter phase II trial in patients with HCC to evaluate the efficacy and safety of SM-11355, usi...

Full description

Bibliographic Details
Main Authors: Okusaka, Takuji, Kasugai, Hiroshi, Ishii, Hiroshi, Kudo, Masatoshi, Sata, Michio, Tanaka, Katsuaki, Shioyama, Yasukazu, Chayama, Kazuaki, Kumada, Hiromitsu, Yoshikawa, Masaharu, Seki, Toshihito, Saito, Hidetugu, Hayashi, Naoaki, Shiratori, Keiko, Okita, Kiwamu, Sakaida, Isao, Honda, Masao, Kusumoto, Yukio, Tsutsumi, Takuya, Sakata, Kenji
Format: Online
Language:English
Published: Springer US 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432786/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432786/

Similar Items